Gilead Sciences (GILD) Invested Capital (2009 - 2026)
Gilead Sciences (GILD) recorded Invested Capital of $38.08 billion in Q2 2026, down 14.5% from $44.54 billion a year earlier and down 16.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Invested Capital (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences reported Invested Capital of $47.64 billion, up 3.7% from FY2024.
- Annual Invested Capital has a five-year compound annual growth rate of -0.8% (FY2020 to FY2025).
- Across earlier years, Invested Capital came in at $45.96 billion in FY2024 (-3.7%), $47.74 billion in FY2023 (+2.8%), $46.44 billion in FY2022 (-2.8%) and $47.76 billion in FY2021 (-3.8%).
- The Q2 2026 figure is the lowest quarterly Invested Capital since Q1 2016.
- On a year-over-year basis, Invested Capital rose in five of the last eight quarters, with an average decline of 0.1%.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 11.6% in Q3 2025, against a decline of 14.5% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $45.61 billion (Q1 2026), $47.64 billion (Q4 2025) and $46.48 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.08 Bn |
| Mar 31, 2026 | 45.61 Bn |
| Dec 31, 2025 | 47.64 Bn |
| Sep 30, 2025 | 46.48 Bn |
| Jun 30, 2025 | 44.54 Bn |
| Mar 31, 2025 | 44.03 Bn |
| Dec 31, 2024 | 45.96 Bn |
| Sep 30, 2024 | 41.64 Bn |
| Jun 30, 2024 | 41.55 Bn |
| Mar 31, 2024 | 42.65 Bn |
| Dec 31, 2023 | 47.74 Bn |
| Sep 30, 2023 | 47.22 Bn |
| Jun 30, 2023 | 46.34 Bn |
| Mar 31, 2023 | 46.18 Bn |
| Dec 31, 2022 | 46.44 Bn |
| Sep 30, 2022 | 46.28 Bn |
| Jun 30, 2022 | 46.43 Bn |
| Mar 31, 2022 | 46.12 Bn |
| Dec 31, 2021 | 47.76 Bn |
| Sep 30, 2021 | 49.16 Bn |
API Access
Gilead Sciences Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();